Jinan Mingxin Pharmaceutical Co., Ltd(formerly Jinan Mingshui Pharmaceutical Factory) was founded in 1989, and completed the reform of joint-stock company from state-owned enterprise with registered capital of 50 million Yuan in 2002. For many years, the company is specialized in the pharmaceutical field, and now has become a large-scale modern high-tech pharmaceutical enterprise focusing on scientific research, production and sale.

Jinan Mingxin Pharmaceutical Co., Ltd is located in the eastern suburb of the capital of Shandong province, and the northern part of Highway“Jinan-Qingdao”. It needs only 20 minutes' drive from Jinan International Airport, 300 kms away from one of China's largest cargo throughput ports–Qingdao. The company covers an area of 68,000 square meters, construction area of 42,000 square meters. The company’s fixed assets are 120 million Yuan, and net assets are 95 million Yuan. The company’s existing staff is 380 people, including 16 engineers, 8 graduate students, 30 undergraduates, and 120 specialist students.

Jinan Mingxin Pharmaceutical Co., Ltd owns over 30 varieties of products, including the leading Active Pharmaceutical Ingredients (API’s) Inosine, Ribavirin, Adenosine Triphosphate Disodium, Buflomedil Hydrochloric, Terbinafine Hydrochloride, Adenosine Cyclophosphate , Pantoprazole Sodium, Nateglinide, etc.; the leading pharmaceutical intermediates (PI’s) Tetraacetyl Ribose, Adenosine, Cytidine, Hypoxanthine, Phenazepam, etc.; the leading preparations Matrine tablets, Omeprazole Enteric-coated capsules, Adenosine Disodium Triphosphate tablets, Inosine tablets, Buflomedil tablets, Terbinafine tablets and so on.. All drugs produced by the company have got national approval and GMP certificates. Several products are registered abroad, like Inosine, Ribavirin, etc. All products are not only selling in domestic market very well, but also in foreign market such as the United States, Canada, Britain, Italy, Russia, Japan, India and others. Product quality and services have gained wide reputation.

To promote the development, the company has signed long-term cooperation agreement with Tsinghua University, East China University of Science and Technology, and Shandong Academy of Medical Sciences focusing on research and development of new drugs. The company is going to increase 4-6 newly developed drugs annually to become one of the strongest pharmaceutical enterprises.

Persisting on the principle "Develop Mingxin Pharmacy, Benefit the People's Health!", the company constantly strengthens the enterprise core competitive power, and strives to make due efforts and contributions for the progress of the Chinese pharmaceutical industry.